Inventor profile of:

Paul Chaplin

City:

Grafelfing

Country:

Germany

Published Applications:

13

Last publication date:

2019-04-25

Top Assignees for applications by Paul Chaplin

The entities that hold a legal rights for patent applications filed by inventor Chaplin Paul:

Recent patent applications by Chaplin Paul

Paul Chaplin from Grafelfing, DE has applied for patents for these inventions. The list has both pending applications and granted patents:

#1 | 2019-04-25
US20190117764A1
Human necessities

Recombinant modified vaccinia virus ankara (MVA) respiratory syncytial virus (RSV) vaccine

#2 | 2017-11-16
US20170326228A1
Human necessities

Recombinant modified vaccinia virus Ankara (MVA) Respiratory Syncytial Virus (RSV) vaccine

#3 | 2017-03-23
US20170081642A1
Chemistry; metallurgy

RECOMBINANT POXVIRUS VECTOR COMPRISING TETANUS TOXIN FRAGMENT C

#4 | 2017-02-16
US20170043008A1
Human necessities

Recombinant modified vaccinia virus ankara (MVA) respiratory syncytial virus (RSV) vaccine

#5 | 2015-07-30
US20150209421A1
Human necessities

Recombinant modified vaccinia virus ankara (MVA) respiratory syncytial virus (RSV) vaccine

#6 | 2015-06-25
US20150174238A1
Human necessities

Poxviral vectors for low antibody response after a first priming immunization

#7 | 2014-11-20
US20140341946A1
Human necessities

Use of a modified poxvirus for the rapid induction of immunity against a poxvirus or other infectious agents

#8 | 2014-10-30
US20140322265A1
Human necessities

Recombinant poxvirus vector comprising tetanus toxin fragment C

#9 | 2012-12-27
US20120328650A1
Chemistry; metallurgy

MODIFIED VACCINIA ANKARA VIRUS VARIANT

#10 | 2012-11-01
US20120276613A1
Human necessities

Modified Vaccinia Ankara virus variant and cultivation method

#11 | 2012-07-19
US20120183574A1
Human necessities

MODIFIED VACCINIA VIRUS ANKARA FOR THE VACCNATION OF NEONATES

#12 | 2012-05-31
US20120135032A1
Human necessities

GENERATION OF A BROAD T-CELL RESPONSE IN HUMANS AGAINST HIV

#13 | 2012-05-03
US20120107359A1
Human necessities

Use of a modified poxvirus for the rapid induction of immunity against a poxvirus or other infectious agents

InventorID:

952787 ⎘